Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors, Am J Epidemiol. 2001; 154: 357-365.
Joynson DH. Epidemiology of toxoplasmosis in the U.K. Scand J Infect Dis. 1992; 84 (Suppl): 65-69
Smith KL, Wilson M, Hightower AW, et al. Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: comparison with data published in 1965. Clin Infect Dis. 1996;23: 1182-1183
de Amorim Garcia CA, Orefice F, de Oliveira Lyra C, et al. Socioeconomic conditions as determining factors in the prevalence of systemic and ocular toxoplasmosis in Northeastern Brazil. Ophthalmic Epidemiol. 2004; 11:301-317
Holland GN. Ocular toxoplasmosis: a global reassessment, Part I: epidemiology and course of disease. Am J Ophthalmol. 2003; 136: 973-988
Stanford MR, See SE, Jones LV, Gilbert RE. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology 2003; 110: 926-931
Holliman RE, Stevens PJ, Duffy KT, Johnson JD. Serological investigation of ocular toxoplasmosis. Br J Ophthalmol. 1991;75: 353-355
Chapman DJ, Ashburn D, Ogston SA, Ho-Yen DO. The relationship between ocular toxoplasmosis and levels of specific toxoplasma antibodies. Epidemiol Infect. 1999;122:299-303
Bou G, Figueroa MS, Marti-Belda P, et al. Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis. J Clin Microbiol. 1999; 37: 3465-3468
Jones CD, Okhravi N, Adamson P, et al. Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of T. gondii in aqueous humor. Invest Ophthalmol Vis Sci. 2000; 41:634-644
Bastien P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg. 2002; 96 (Suppl 1): S205-S215
de Boer JH, Verhagen C, Bruinenberg M, et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996;121: 650-658
Fardeau C, Romand S, Rao NA, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 2002; 134: 196-203
Garweg J, Boehnke M, Koerner F. Restricted applicability of the polymerase chain reaction for the diagnosis of ocular toxoplasmosis. Ger J Ophthalmol. 1996; 5: 104-108
Garweg JG, Jacquier P, Boehnke M. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol. 2000; 38: 996-1001
Labalette P, Delhaes L, Margaron F, Fortier B, Rouland JF. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol. 2002; 133: 506-515
Fekkar A, Bodaghi B, Touafek F, et al. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2008; 46: 1965-1967
Danise A, Cinque P, Vergani S, et al. Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus. Clin Infect Dis. 1997; 24: 1100-1106
Garweg JG. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol. 2005; 27:61-68
De Groot-Mijnes JDF, Rothova A, Van Loon AM, et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am J Ophthalmol. 2006; 141: 313-318
Montoya JG, Parmley S, Liesenfeld O, et al. Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosis. Ophthalmology. 1999; 106: 1554-1563
Bornand JE, de Gottrau P. Uveitis: is ocular toxoplasmosis only a clinical diagnosis? Ophthalmologica. 1997; 211:87-89
Kijlstra A. The value of laboratory testing in uveitis. Eye. 1990; 4: 732-736
Klaren VN, Peek R. Evidence for a compartmentalized B cell response as characterized by IgG epitope specificity in human ocular toxoplasmosis. J Immunol. 2001; 167:6263-6269
Turunen HJ, Leinikki PO, Saari KM. Demonstration of intraocular synthesis of immunoglobulin G Toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay. J Clin Microbiol. 1983; 17:988-992
Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol. 1999; 128: 407-412
Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusally high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthal 1992; 114: 136-144
Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet. 1997; 350: 173-177.
Bonfioli AA; Orefice F. Toxoplasmosis. Semin Ophthalmol. 2005; 20: 129-41
Desmonts G. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol. 1966; 76: 839-851
Goldmann H, Witmer R. Antikörper im Kammerwasser. Ophthalmologica. 1954; 127: 323-330
Kijlstra A, Luyendijk L, Baarsma GS, et al. Aqueous humor analysis as a diagnostic tool in toxoplasma uveitis. Int Ophthalmol. 1989; 13: 383-386
Liekfeld A, Schweig F, Jaeckel C, et al. Intraocular antibody production in intraocular inflammation. Graefes Arch Clin Exp Ophthalmol. 2000; 238: 222-227
Vinhal FA, Pena JD, Katina JH, et al. Analysis of aqueous humor in ocular toxoplasmosis: detection of low avidity IgG specific to Toxoplasma gondii. Appl Parasitol. 1994; 35: 1-7
Villard O, Filisetti D, Roch-Deries F, et al. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol. 2003; 41: 3537-3541
Fawzy M, Mahmoud LA, El Gindy AE, et al. Value of estimating intraocular antibody production in diagnosis of typical and atypical lesions of ocular toxoplasmosis. J Egypt Soc Parasitol. 1999; 29: 735-743
De Marco R, Ceccarelli R, Frulio R, et al. Retinochoroiditis associated with congenital toxoplasmosis in children: IgG antibody profiles demonstrating the synthesis of local antibodies. Eur J Ophthalmol. 2003;13:74-79
Klaren VN, van Doornik CE, Ongkosuwito JV, et al. Differences between intraocular and serum antibody responses in patients with ocular toxoplasmosis. Am J Ophthalmol. 1998; 126: 698-706
Riss JM, Carboni ME, Franck JY, et al. Ocular toxoplasmosis: value of immunoblotting for the determination of an intraocular synthesis of antibodies. Pathol Biol (Paris). 1995; 43:772-778
Garweg JG, Garweg SDL, Flueckiger F, et al. Aqueous humor and serum Immunoblotting for Immunoglobulin G, A, M, and E antibodies in human ocular toxoplasmosis. J Clin Microbiol. 2004; 42: 4593-4598
Garweg JG, Sobottka Ventura AC, Halberstadt M, et al. Specific Antibody levels in the aqueous humor and serum of two distinct populations of patients with ocular toxoplasmosis. Int J Med Microbiol. 2005; 295: 287-295
Garweg JG, Boehnke M. Determinants of antibody response in experimental ocular toxoplasmosis. Graefe's Arch Clin Exp Ophthalmol. 2006; 244: 1668-1679
de Visser L, Rothova A, de Boer JH, et al. Diagnosis of ocular toxocariasis by establishing intraocular antibody production. Am J Ophthalmol. 2008; 145: 369-374
Schwab IR. The epidemiologic association of Fuchs' heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol. 1991; 111: 356-362
La Hey E, Rothova A, Baarsma GS, et al. Fuchs' heterochromic iridocyclitis is not associated with ocular toxoplasmosis. Arch Ophthalmol. 1992; 110: 806-811
Dao A, Fortier B, Soete M, et al. Successful reinfection of chronically infected mice by a different Toxoplasma gondii genotype. Int J Parasitol. 2001; 31: 63-65
Vallochi AL, Muccioli C, Martins MC, et al. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol. 2005; 139: 350-351
Honoré S, Couvelard A, Garin YJ, et al. [Genotyping of Toxoplasma gondii strains from immunocompromised patients]. Pathol Biol (Paris). 2000; 48: 541-547
Peyron F, Lobry JR, Musset K, et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia. Microbes Infect. 2006; 8: 2333-2340
Morisset S, Peyron F, Lobry JR, et al. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect. 2008; 10: 742-747
